Key insights
- Keefe Bruyette raised its price target on Marsh & McLennan (MRSH) to $203, citing strong growth prospects and margin expansion. While the firm maintains a Market Perform rating, the increased target and positive earnings revisions suggest continued solid performance. The stock is considered fairly valued, but InvestingPro analysis indicates potential undervaluation. The company's consistent dividend increases further support a positive outlook, although the overall impact on the broader US equity market is limited.
Investing.com - Keefe, Bruyette & Woods raised its price target on Marsh & McLennan Companies Inc. stock (NYSE:MRSH) to $203 from $200 on Thursday while maintaining a Market Perform rating.
The firm increased its 2026 and 2027 operating cash earnings per share estimates to $10.45 and $11.60 from $10.30 and $11.40, respectively. The revision reflects first-quarter 2026 outperformance and expectations for higher organic growth and margins in the RIS and Consulting segments, along with lower share counts, partly offset by lower Corporate operating income.
Keefe Bruyette expects Marsh’s Thrive program to drive margin expansion in 2026 and 2027. The firm anticipates strong execution will sustain steady earnings growth despite softening commercial pricing.
The new price target of $203 represents 17.5 times the firm’s updated 2027 cash earnings per share estimate. Marsh shares trade at 15.7 times the firm’s 2027 cash earnings per share estimate versus a 14.5 times median multiple for large-cap brokers. The stock currently carries a P/E ratio of 22.4 and trades at a Price/Book multiple of 6.04.
The firm views Marsh shares as fairly valued at current levels. According to InvestingPro analysis, the stock appears undervalued based on its Fair Value calculation, placing it among opportunities on the Most Undervalued list. The company has raised its dividend for 16 consecutive years, one of several insights available in the comprehensive Pro Research Report covering MRSH and 1,400+ other US equities.
In other recent news, Marsh & McLennan Companies reported first-quarter results that surpassed analyst expectations, with adjusted earnings per share reaching $3.29 and total revenue climbing to $7.6 billion. This performance represents an 8% increase in revenue, exceeding BofA Securities’ previous estimate of 4%. RBC Capital maintained its Sector Perform rating on Marsh stock, citing a strong start to the year despite macroeconomic challenges. Mizuho also raised its price target to $194, noting an increase in its 2026 earnings per share estimate to $10.45 after a first-quarter beat of $0.07. However, Mizuho adjusted its forecasts for the second and fourth quarters of 2026, anticipating margin improvements later in the year. BofA Securities raised its price target to $179, although it maintained an Underperform rating, acknowledging that Marsh’s earnings exceeded both its own and the Street’s consensus estimates. These developments highlight the company’s robust financial performance and the varied perspectives among analysts regarding its future prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.